Ecolab Inc.

(New York Stock Exchange)
Bullish +65

Ecolab stock: RBC sets USD 337.00 target for Ecolab stock

πŸ“ˆ RBC Capital analyst Ashish Sabadra maintained a Buy rating and established a USD 337.00 price target for Ecolab Inc.

πŸ’° The new analyst target is 15.69% higher than the current NYSE trading price of USD 291.32 as of October 16, 2026.

πŸ“Š Ecolab reported Q2 revenue of USD 4.42 billion and net income of USD 534.9 million for the period ended June 30, 2026.

πŸ’΅ Operating cash flow for the second quarter reached USD 729.5 million, supporting the company's valuation metrics.

πŸ“‰ The stock trades at a P/E ratio of 39.07 with a market capitalization of USD 81.7 billion as of October 16, 2026.

🌍 Ecolab provides water, hygiene, and infection prevention solutions across four operating segments including Global Water.

πŸ“… The company's next scheduled earnings reporting date is set for October 27, 2026.

πŸ“ˆ The stock's 52-week trading range spans from USD 243.15 to USD 309.27, with the current price near the upper end.

πŸ‡©πŸ‡ͺ German investors can reference a EUR 259.05 quotation at Lang & Schwarz alongside the primary NYSE listing.

Bullish Signals
  • RBC Capital analyst Ashish Sabadra maintained a Buy rating and set a USD 337.00 price target, implying significant upside potential relative to current market levels.
  • The company delivered robust Q2 financial results with revenue of USD 4.42 billion and net income of USD 534.9 million, demonstrating strong operational execution.
  • Ecolab generated substantial operating cash flow of USD 729.5 million in the second quarter, providing a healthy liquidity buffer for future investments or dividends.
  • The stock is trading near its 52-week high of USD 309.27, indicating strong investor confidence and bullish market sentiment around the current valuation.
Full Analysis
Ecolab Inc. received a price target update from RBC Capital, which maintained its Buy rating and set a new USD 337.00 price objective for the stock on October 14, 2026. This target represents a 15.69% premium over Ecolab's NYSE trading price of USD 291.32 recorded on October 16, 2026, providing analysts with a clear valuation reference point in the company's home currency. The company reported strong financial performance for its second quarter ended June 30, 2026, with revenue reaching USD 4.42 billion and net income attributable to common shareholders totaling USD 534.9 million. Diluted earnings per share stood at USD 1.90, while operating cash flow was reported at USD 729.5 million, offering a solid anchor for the ongoing valuation discussion. Ecolab operates across four segments providing water, hygiene, and infection prevention solutions, including its Global Water and Global Life Sciences divisions. As of October 16, 2026, the company held a market capitalization of USD 81.7 billion with a P/E ratio of 39.07, trading within a 52-week range between USD 243.15 and USD 309.27. The stock traded at EUR 259.05 on the Xetra exchange in Germany, reflecting continued investor interest alongside its primary listing on the NYSE. With an average daily trading volume of approximately 1.3 million shares, Ecolab maintains active liquidity as it prepares for its next scheduled reporting date on October 27, 2026.